465.11MMarket Cap-4933P/E (TTM)
9.190High8.450Low699.61KVolume8.960Open8.800Pre Close6.13MTurnover2.04%Turnover RatioLossP/E (Static)52.08MShares30.99052wk High1.86P/B306.23MFloat Cap5.67052wk Low--Dividend TTM34.29MShs Float72.200Historical High--Div YieldTTM8.41%Amplitude2.190Historical Low8.760Avg Price1Lot Size
EyePoint Pharmaceuticals Stock Forum
NEWS
EyePoint Pharmaceuticals Trial of Duravyu in Diabetic Eye Disease Fails to Meet Primary Endpoint
Larger Image: tradingview.com...
$EyePoint Pharmaceuticals(EYPT.US)$
$EyePoint Pharmaceuticals(EYPT.US)$
$Adverum Biotechnologies(ADVM.US)$
$Regenxbio(RGNX.US)$
$4D Molecular Therapeutics(FDMT.US)$
$Kodiak Sciences(KOD.US)$
📊⚡️📊
No comment yet